(NP (NP (NN Characterization)) (PP (IN of) (NP (DT the) (JJ human) (JJ myeloid) (NN cell) (JJ nuclear) (NN differentiation) (NN antigen) (NN gene) (NN promoter))) (. .))
(S (NP-SBJ (NP (NN MNDA)) (PRN (-LRB- -LRB-) (NP (JJ myeloid) (NN cell) (JJ nuclear) (NN differentiation) (NN antigen)) (-RRB- -RRB-))) (VP (VBZ is) (NP-PRD (NP (DT an) (ADJP (NP (NN interferon) (NN alpha)) (VBN regulated)) (JJ nuclear) (NN protein)) (VP (VBN expressed) (NP (-NONE- *)) (PP (RB only) (IN in) (NP (NP (NNS cells)) (PP (IN of) (NP (DT the) (JJ human) (JJ myelomonocytic) (NN lineage)))))))) (. .))
(S (S (NP-SBJ (-NONE- *)) (VP (TO To) (VP (VB identify) (NP (NP (NNS mechanisms)) (ADJP (JJ responsible) (PP (IN for) (NP (DT this) (ADJP-COOD (ADJP (JJ lineage-specific)) (CC and) (ADJP (JJ interferon-regulated))) (NN expression)))))))) (, ,) (NP-SBJ-34 (NP (DT the) (JJ 5') (JJ flanking) (NN sequence)) (PP (IN of) (NP (DT the) (NN gene)))) (VP (VBZ has) (VP (VBN been) (VP (VBN characterized) (NP (-NONE- *-34))))) (. .))
(S (NP-SBJ (CD Two) (NP (NP (JJ interferon-stimulated) (NN response) (NNS elements)) (PRN (-LRB- -LRB-) (NP (NN ISRE)) (-RRB- -RRB-)))) (VP (VBP flank) (NP (NP (DT a) (JJ multiple) (NN transcription) (NN start) (NN site) (NN region)) (VP (VBG identifying) (NP (NN MNDA)) (PP (IN as) (NP (DT a) (JJ TATA-less) (JJ interferon-regulated) (NN gene)))))) (. .))
(S (NP-SBJ (NP (JJ Other) (NN DNA) (NNS elements)) (ADJP (JJ present))) (VP (VBP include) (NP (NP-COOD (NP (NP (DT a) (NN cluster)) (PP (IN of) (NP (NN Myb) (NNS sites)))) (, ,) (NP (JJ several) (NNS Ets)) (, ,) (NP (DT an) (ADJP (NN Ets) (JJ related)) (NN PU.1) (NN site)) (CC and) (NP (DT an) (NN Sp1) (NN site))) (ADJP (JJ located) (PP (IN within) (NP (NP (CD 600) (NN bp)) (PP (IN of) (NP (DT the) (NN transcription) (NN start) (NNS sites)))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ-35 (NN DNA) (NN methylation)) (VP (VBD was) (VP (VBN revealed) (NP (-NONE- *-35)) (PP (IN as) (NP (NP (CD one)) (PP (IN of) (NP (DT the) (JJ possible) (NNS factors))) (PP (IN in) (S (NP-SBJ (-NONE- *)) (VP (VBG establishing) (NP (NN MNDA) (NN expression))))))))) (. .))
(S (NP-SBJ (DT The) (JJ 5') (JJ flanking) (NN sequence)) (VP (VBZ has) (NP (NP (NN promoter) (NN activity)) (SBAR (WHNP-37 (WDT which)) (S (NP-SBJ-38 (-NONE- *T*-37)) (VP (VBZ is) (VP (VBN elevated) (NP (-NONE- *-38)) (PP (IN by) (NP-LGS (NN interferon) (NN alpha))))))))) (. .))
(S (NP-SBJ (DT The) (NNS findings)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ-39 (NN MNDA) (NN expression)) (VP (VBZ is) (VP (VBN regulated) (NP (-NONE- *-39)) (PP (IN by) (NP-LGS (NP (NNS mechanisms)) (ADJP (JJ similar) (PP (TO to) (NP-COOD (NP (JJ other) (ADJP (NP (JJ myelomonocytic) (NN cell)) (JJ specific)) (NNS genes)) (CC and) (NP (NP (NNS genes)) (VP (VBN up-regulated) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN interferon) (NN alpha))))))))))))))) (. .))
